Implication of Serious Infections in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis for the First Cycle of Rituximab: A Pilot Study in a Single Korean Center.
Risk factors for severe bacterial infections in patients with systemic autoimmune diseases receiving rituximab.